To examine whether expression of PHLDA2 enhances sensitivity of NSCLC cells to targeted agents, MTS cell proliferation assay was used to assess the role of PHLDA2 in lapatinib sensitivity of ErbB2-positive cancer cells. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.